ANOVA F-test results and regulators [🇷 for BE/BA]

posted by d_labes  – Berlin, Germany, 2015-06-12 17:23 (3661 d 04:28 ago) – Posting: # 14950
Views: 14,687

Dear Helmut,

❝ ...

❝ ❝ But regulators like to see some sort of effect tests in the ANOVA ...


❝ ... I never gave anything but the PE and CI in the main text of my reports (the complete eva­lu­ation only in the appendix).


Here we are two, or more than 2 :cool:

❝ Although some assessors or inspectors routinely re­cal­cu­late studies (in SAS or in the semi-secret WinBE?) I never received a ques­tion. Maybe they compared only the CI, which – as you said – is the only relevant part.


May I call you Felix the Fortunate, the Happy? :-D

We received then and when (not so seldom!) questions about the ANOVA F-test results. Up to the request to comment significant results even for the treatment effects, of no relevance in case of BE studies of course.
Nasty the requests to comment the "validity" of the BE evaluation if period and/or sequence effects are found significant. As they many times come out if Type I tests will be applied, especially for sequence.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
41 visitors (0 registered, 41 guests [including 12 identified bots]).
Forum time: 21:52 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5